Advertisement

Minnesota's Investment in Tobacco Control

Research Findings to Inform Practice and Policy
      Minnesota has a long history of leadership in tobacco control, dating back to a 1975 Clean Indoor Air law limiting smoking indoors. In 1998, a settlement was reached to a lawsuit the state and Blue Cross and Blue Shield of Minnesota had brought against cigarette manufacturers and related trade associations accusing them of failing to disclose information about the dangers and addictive qualities of cigarettes. As part of the settlement, the nonprofit organization ClearWay MinnesotaSM was created to reduce tobacco use and exposure to secondhand smoke through research, action, and collaboration.
      • Schillo B.
      • D' Silva J.
      ClearWay Minnesota's research program investing in innovative tobacco control research to improve the health of Minnesotans.
      In 2001, a statewide educational media campaign and quitline were implemented. By the end of 2006, most major population centers in Minnesota had some form of a smokefree ordinance in place.
      CDC
      Decrease in smoking prevalence—Minnesota, 1999–2010.
      Local policy efforts culminated in 2007 with the passage of a comprehensive statewide law, the Freedom to Breathe Act, which banned smoking in all indoor workplaces, including restaurants and bars.
      • Bruswick M.
      New smoking ban.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to American Journal of Preventive Medicine
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Schillo B.
        • D' Silva J.
        ClearWay Minnesota's research program investing in innovative tobacco control research to improve the health of Minnesotans.
        Am J Prev Med. 2008; 35: S439-S441
        • CDC
        Decrease in smoking prevalence—Minnesota, 1999–2010.
        MMWR Morb Mortal Wkly Rep. 2011; 60: 138-141
        • Bruswick M.
        New smoking ban.
        Star Tribune. 2007, Sep 30;
        • Bernat D.H.
        • Choi K.
        • Erickson D.J.
        • Lenk K.M.
        • Forster J.L.
        Minnesota's comprehensive statewide smokefree law: short-term effects on young adults.
        Am J Prev Med. 2012; 43: S156-S162
        • Betzner A.E.
        • Boyle R.G.
        • Luxenberg M.G.
        • et al.
        Experience of smokers and recent quitters with smokefree regulations and quitting.
        Am J Prev Med. 2012; 43: S163-S170
        • Schillo B.A.
        • Keller P.A.
        • Betzner A.E.
        • Greenseid L.
        • Christenson M.
        • Luxenberg M.
        Minnesota's smokefree policies: impact on cessation program participants.
        Am J Prev Med. 2012; 43: S171-S178
        • Levy D.T.
        • Boyle R.G.
        • Abrams D.B.
        The role of public policies in reducing smoking: the Minnesota SimSmoke tobacco policy model.
        Am J Prev Med. 2012; 43: S179-S186
        • Hewett M.J.
        • Ortland W.H.
        • Brock B.E.
        Secondhand smoke and smokefree policies in owner-occupied multi-unit housing.
        Am J Prev Med. 2012; 43: S187-S196
        • St. Claire A.W.
        • Boyle R.G.
        • Schillo B.A.
        • Rode P.
        • Taylor K.A.
        Smokefree home rules adoption by smokers and nonsmokers: Minnesota, 1999–2010.
        Am J Prev Med. 2012; 43: S197-S204
        • Giuliani K.K.W.
        • Mire O.
        • Leinberger-Jabari A.
        • et al.
        Cigarettes and the Somali diaspora: tobacco use among Somali adults in Minnesota.
        Am J Prev Med. 2012; 43: S205-S213
        • Horvath K.J.
        • Eastman M.
        • Prosser R.
        • Goodroad B.
        • Worthington L.
        Addressing smoking during medical visits: patients with human immunodeficiency virus.
        Am J Prev Med. 2012; 43: S214-S221
        • Nadeau M.
        • Blake N.
        • Poupart J.
        • Rhodes K.
        • Forster J.
        Circles of tobacco wisdom: learning about traditional and commercial tobacco with Native elders.
        Am J Prev Med. 2012; 43: S222-S228
        • Berg C.J.
        • Schauer G.L.
        • Rodgers K.
        • Narula S.K.
        College student smokers: former versus current and nonsmokers.
        Am J Prev Med. 2012; 43: S229-S236
        • Weisman S.R.
        • Hennrikus D.
        • Choi K.
        • et al.
        Influencing Taft–Hartley funds to provide tobacco cessation benefits.
        Am J Prev Med. 2012; 43: S237-S241
        • D'Silva J.
        • Boyle R.G.
        • Lien R.
        • Rode P.
        • Okuyemi K.S.
        Cessation outcomes among treatment-seeking menthol and nonmenthol smokers.
        Am J Prev Med. 2012; 43: S242-S248
        • Freiberg M.J.A.
        Federal approaches to the regulation of noncigarette tobacco products.
        Am J Prev Med. 2012; 43: S249-S254
        • Ashley A.L.
        • Backinger C.L.
        The Food and Drug Administration's regulation of tobacco: The Center for Tobacco Products' Office of Science.
        Am J Prev Med. 2012; 43: S255-S263
        • Koh H.K.
        Realizing the vision for tobacco control.
        Am J Prev Med. 2012; 43: S264-S265